Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment. | Cancers (Basel) | 2023 | 36765782 | PubTator, text mining | PubMed |
| Translating the Genome into Drugs. | Acc Chem Res | 2023 | 36757774 | PubTator, text mining | PubMed |
| Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII. | J Enzyme Inhib Med Chem | 2023 | 36728712 | PubTator, text mining | PubMed |
| New Insights into Conformationally Restricted Carbonic Anhydrase Inhibitors. | Molecules | 2023 | 36677947 | PubTator, text mining | PubMed |
| Expression of pH-Sensitive TRPC4 in Common Skin Tumors. | Int J Mol Sci | 2023 | 36674553 | PubTator, text mining | PubMed |
| Clinical Characteristics of Coronary-to-Pulmonary Artery Fistula in Patients with Pulmonary Atresia and Ventricular Septal Defect. | J Cardiovasc Dev Dis | 2023 | 36661912 | PubTator, text mining | PubMed |
| Predictive value of admission CO2 combining power combined with serum sodium for the prognosis in acute Stanford type A aortic dissection patients. | Sci Rep | 2023 | 36658204 | PubTator, text mining | PubMed |
| Peptide Drug Conjugates and Their Role in Cancer Therapy. | Int J Mol Sci | 2023 | 36614268 | PubTator, text mining | PubMed |
| Correlation between CFTR variants and outcomes of ART in patients with CAVD in Central China. | Sci Rep | 2023 | 36604502 | PubTator, text mining | PubMed |
| Decellularized matrix for repairing intervertebral disc degeneration: Fabrication methods, applications and animal models. | Mater Today Bio | 2023 | 36590980 | PubTator, text mining | PubMed |
| The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus. | Neurol Ther | 2023 | 36564664 | PubTator, text mining | PubMed |
| Design and synthesis of new adamantyl derivatives as promising antiproliferative agents. | Eur J Med Chem | 2023 | 36470105 | PubTator, text mining | PubMed |
| Novel benzenesulfonamide-thiouracil conjugates with a flexible N-ethyl acetamide linker as selective CA IX and CA XII inhibitors. | Arch Pharm (Weinheim) | 2023 | 36372524 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Identifying medically relevant xenon protein targets by in silico screening of the structural proteome. | Med Gas Res | 2023 | 35946221 | PubTator, text mining | PubMed |
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| The immunolocalization of HIF-2α, GLUT1 and CAIX in porcine oviduct during the estrous cycle. | Anat Rec (Hoboken) | 2023 | 35684983 | PubTator, text mining | PubMed |
| The investigation of diverse physiological and therapeutic impact of cellular-based products derived from human cumulus cells. | Turk J Biol | 2022 | 37529007 | PubTator, text mining | PubMed |
| Evaluation of risk factors and effective factors in determining the prognosis of ovarian cancer. | Cell Mol Biol (Noisy-le-grand) | 2022 | 36905279 | PubTator, text mining | PubMed |
| Increased response to TPF chemotherapy promotes immune escape in hypopharyngeal squamous cell carcinoma. | Front Pharmacol | 2022 | 36712687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=14